Rituximab in the Treatment of Refractory Myasthenia Gravis: Studying the Outcomes Using MMT Score And Need for Plasmapheresis in Baghdad Teaching Hospital. Indian Journal of Forensic Medicine & Toxicology, [S. l.], v. 14, n. 2, p. 2505–2510, 2020. DOI: 10.37506/ijfmt.v14i2.3485. Disponível em: https://medicopublication.com/index.php/ijfmt/article/view/3485. Acesso em: 22 may. 2026.